logo dark logo light logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS
    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
logo dark logo light logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS
    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
mobile-logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS

    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
27 May

Atmo Biosciences Receives FDA Clearance for Gastrointestinal (GI) Contractility Frequency Map

by Danni Sweeting
in 2026 News, Commercial, News, USA News
Comments
26 May 2026.

Atmo Biosciences is delighted to announce that we have just received US Food and Drug Administration (FDA) 510(k) clearance for a new Contractility Frequency Map feature as an enhancement to the existing Atmo Gas Capsule System.

Continue reading
Read More

Contact

info@atmobiosciences.com

Australia

436 Elgar Rd
Box Hill VIC 3128

United States

Atmo Biosciences Inc.
7625 Golden Triangle Dr., Ste G
Eden Prairie, MN 55344
  • Clinician Portal Login
  • Support and Resources
  • Privacy Policy
  • USA
  • Terms and Conditions of Sale
  • Business Associate Agreement

© Atmo Biosciences 2026

loading

Please wait while you are redirected to the right region...